Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ian T. Clark currently holds 29,500 shares of Kite Pharma, Inc. (KITE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ian T. Clark has been a net seller of KITE stock. They have purchased $54.0K and sold $38.0M worth of shares.
Ian T. Clark's most recent insider trade was on Jun 18, 2026, when they sold 29,500 shares at $0.00 per share.
Ian T. Clark serves as Executive at Kite Pharma, Inc. (KITE). They have executed 333 insider transactions totaling $38.1M over their tenure at the company.
Ian T. Clark holds the position of Executive at Kite Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Ian T. Clark has shown a selling trading pattern, with $54.0K in total purchases and $38.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Ian T. Clark was on Dec 19, 2025, when they sold $5.7M worth of OLMA shares. This transaction involved 193,056 shares at $29.71 per share.
Ian T. Clark currently owns 29,500 shares of Kite Pharma, Inc. (KITE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ian T. Clark's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ian T. Clark has 333 Form 4 filings on record as an insider at Kite Pharma, Inc..
Set alerts for Ian T. Clark and 40,000+ other insiders.